📰 Nasdaq Grts News
Nasdaq Grts News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Grts. Real-time updates on events, politics, business and more.
April 2, 2024
Gritstone bio, Inc. (NASDAQ:GRTS – Get Free Report) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 8,820,000 shares, an increase of 7.3% from the February 29th total of 8,220,000 shares. Approximately 9.9% of the shares of the company are sold short. Based […]
March 26, 2024
Twin Peaks Wealth Advisors LLC acquired a new stake in Gritstone bio, Inc. (NASDAQ:GRTS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 40,314 shares of the company’s stock, valued at approximately $82,000. Several other large investors also recently added to or […]
January 27, 2024
Forum Financial Management LP increased its holdings in Gritstone bio, Inc. (NASDAQ:GRTS – Free Report) by 78.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,799 shares of the company’s stock after purchasing an additional 7,799 shares during the quarter. Forum Financial Management LP’s […]
December 5, 2023
Gritstone bio, Inc. (NASDAQ:GRTS – Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 8,420,000 shares, a decrease of 7.7% from the October 31st total of 9,120,000 shares. Based on an average trading volume of 2,290,000 shares, the short-interest ratio […]
September 13, 2023
EMERYVILLE, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop...
May 27, 2023
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) insider Vassiliki Economides bought 12,000 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The shares were bought at an average cost of $1.90 per share, with a total value of $22,800.00. Following the transaction, the insider now directly owns 214,058 shares of the company’s […]
May 25, 2023
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) insider Vassiliki Economides acquired 12,000 shares of Gritstone bio stock in a transaction dated Tuesday, May 23rd. The shares were purchased at an average price of $1.90 per share, with a total value of $22,800.00. Following the acquisition, the insider now owns 214,058 shares of the company’s stock, […]
March 31, 2023
B. Riley started coverage on shares of Gritstone bio (NASDAQ:GRTS – Get Rating) in a research report released on Tuesday, Marketbeat reports. The firm issued a buy rating and a $8.00 target price on the stock. B. Riley also issued estimates for Gritstone bio’s Q1 2023 earnings at ($0.32) EPS, Q2 2023 earnings at ($0.35) […]
March 30, 2023
Equities research analysts at B. Riley started coverage on shares of Gritstone bio (NASDAQ:GRTS – Get Rating) in a research note issued on Tuesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the stock. B. Riley’s price target indicates a potential upside of 200.75% from the stock’s previous […]
February 27, 2023
EMERYVILLE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the...